This study reveals that METTL1 plays an important role in driving cardiac hypertrophy by regulating the SRSF9/NFATc4 axis, suggesting that targeting METTL1 could be an efficient way to treat cardiac hypertrophy and HF. This evidence concerns the gene SRSF9 and cardiac hypertrophy.